read more

first_imgFeature | February 28, 2014 First Pediatric Patient Treated on Mevion S250 Proton Therapy System News | Radiation Therapy | August 15, 2019 First Patient Enrolled in World’s Largest Brain Cancer Clinical Trial Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive… read more Feature | August 05, 2019 | Dave Fornell, Editor Most Popular Radiology and Radiotherapy Topics in July 2019 August 5, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine website fr read more News | Radiation Therapy | August 02, 2019 Varian Showcases Cancer Care Systems and Software at AAPM 2019 Varian showcased systems and software from its cancer care portfolio, including the Identify Guidance System, at the… read more Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications Catalyst PT image courtesy of C-RAD News | Patient Positioning Radiation Therapy | August 15, 2019 Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton… read more Related Content News | Brachytherapy Systems | August 14, 2019 Efficacy of Isoray’s Cesium Blu Showcased in Recent Studies August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica read more The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec. News | Proton Therapy | August 08, 2019 MD Anderson to Expand Proton Therapy Center The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a… read more News | Radiation Therapy | August 16, 2019 Drug Accelerates Blood System’s Recovery After Radiation, Chemotherapy A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem… read more News | Proton Therapy | August 06, 2019 IBA Signs Contract to Install Proton Therapy Center in Kansas IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution… read more February 28, 2014 — A 6-year-old with a highly malignant medulloblastoma brain tumor is the first pediatric patient treated using the Mevion S250 proton therapy system at Washington University Medical Center in St. Louis. This milestone event marks the first pediatric case ever treated on the world’s only single-room proton therapy system.The Mevion S250 proton therapy system is a wholly unique proton therapy platform — a single-room, gantry-mounted proton accelerator that frees hospitals and private treatment facilities from the astronomical costs, prohibitive space requirements and technologically cumbersome systems that to date have defined this effective treatment modality.The clinical team at S. Lee Kling Proton Therapy Center at Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, along with doctors at St. Louis Children’s Hospital, is using the Mevion S250 for the treatment of brain, head and neck, and pediatric tumors, as well as other proton therapy indications.Proton therapy delivers precise doses of radiation while limiting unnecessary radiation to healthy tissues, potentially reducing side effects and improving patient outcomes. “We selected proton therapy to be a part of this patient’s treatment plan due to the child’s age and the location of the tumor,” said Stephanie Perkins, M.D., a Washington University radiation oncologist at St. Louis Children’s Hospital. “Today’s treatment lasted less than 45 minutes with the radiation beam hitting the tumor from three directions.”Mevion’s ability to provide this advanced treatment in a compact and integrated form is an industry first, leading the way in providing patients and clinicians’ access to the advanced treatment techniques proton therapy delivers in a far more cost-effective manner.Five additional Mevion S250 proton therapy systems are under installation at Robert Wood Johnson University Hospital in New Brunswick, N.J.; Stephenson Cancer Center at the University of Oklahoma in Oklahoma City; First Coast Oncology in Jacksonville, Fla.; University of Florida Health Cancer Center at Orlando Health; and University Hospitals Seidman Cancer Center in Cleveland.For more information: www.mevion.com FacebookTwitterLinkedInPrint分享 The top piece of content in July was a video interview explaining how Princess Margaret Cancer Center is using machine learning to create automated treatment plans. This was a hot topic at the American Association of Physicists in Medicine (AAPM) 2019 meeting in July.  News | Patient Positioning Radiation Therapy | August 07, 2019 Qfix kVue One Proton Couch Top Validated by Mevion Medical Systems Qfix and Mevion Medical Systems announced that a special version of the kVue One Proton couch top is now both validated… read more News | Radiation Oncology | July 31, 2019 Laura Dawson, M.D., FASTRO, Chosen as ASTRO President-elect The members of the American Society for Radiation Oncology (ASTRO) elected four new officers to ASTRO’s Board of… read morelast_img

Leave a Reply

Your email address will not be published. Required fields are marked *